SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
SEC Accession No. 0001193125-24-047460
Filing Date
2024-02-27
Accepted
2024-02-27 11:35:37
Documents
10
Period of Report
2024-02-27

Document Format Files

Seq Description Document Type Size
1 6-K d702412d6k.htm 6-K 11525
2 EX-99.1 d702412dex991.htm EX-99.1 22371
3 EX-99.2 d702412dex992.htm EX-99.2 29170
4 EX-99.3 d702412dex993.htm EX-99.3 13113
5 EX-99.4 d702412dex994.htm EX-99.4 31970
6 EX-99.5 d702412dex995.htm EX-99.5 23306
7 GRAPHIC g702412g0227051450864.jpg GRAPHIC 2601
8 GRAPHIC g702412g44r63.jpg GRAPHIC 5493
9 GRAPHIC g702412g83w72.jpg GRAPHIC 2315
10 GRAPHIC g702412g86v74.jpg GRAPHIC 1838
  Complete submission text file 0001193125-24-047460.txt   150126
Mailing Address 46 AVENUE DE LA GRANDE ARMEE PARIS I0 75017
Business Address 46 AVENUE DE LA GRANDE ARMEE PARIS I0 75017 33153774400
Sanofi (Filer) CIK: 0001121404 (see all company filings)

IRS No.: 133529324 | State of Incorp.: I0 | Fiscal Year End: 1231
Type: 6-K | Act: 34 | File No.: 001-31368 | Film No.: 24683713
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)